nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—Bacitracin—IDE—type 2 diabetes mellitus	0.0125	0.966	CrCbGaD
Octreotide—SSTR1—pancreas—type 2 diabetes mellitus	0.00334	0.159	CbGeAlD
Octreotide—MPO—artery—type 2 diabetes mellitus	0.00318	0.152	CbGeAlD
Octreotide—SSTR2—kidney—type 2 diabetes mellitus	0.00285	0.136	CbGeAlD
Octreotide—SSTR2—pancreas—type 2 diabetes mellitus	0.00284	0.135	CbGeAlD
Octreotide—MPO—endothelium—type 2 diabetes mellitus	0.00269	0.128	CbGeAlD
Octreotide—SSTR1—liver—type 2 diabetes mellitus	0.00212	0.101	CbGeAlD
Octreotide—MPO—cardiovascular system—type 2 diabetes mellitus	0.0011	0.0527	CbGeAlD
Octreotide—MPO—kidney—type 2 diabetes mellitus	0.00108	0.0516	CbGeAlD
Octreotide—MPO—pancreas—type 2 diabetes mellitus	0.00107	0.0512	CbGeAlD
Octreotide—MPO—liver—type 2 diabetes mellitus	0.000683	0.0326	CbGeAlD
Octreotide—Desmopressin—PTGS2—type 2 diabetes mellitus	0.000448	0.0345	CrCbGaD
Octreotide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000191	0.000332	CcSEcCtD
Octreotide—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000191	0.000332	CcSEcCtD
Octreotide—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000191	0.000332	CcSEcCtD
Octreotide—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000191	0.000332	CcSEcCtD
Octreotide—Shock—Metformin—type 2 diabetes mellitus	0.000191	0.000332	CcSEcCtD
Octreotide—Insomnia—Orlistat—type 2 diabetes mellitus	0.000191	0.000331	CcSEcCtD
Octreotide—Malaise—Losartan—type 2 diabetes mellitus	0.000191	0.000331	CcSEcCtD
Octreotide—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000191	0.000331	CcSEcCtD
Octreotide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00019	0.000331	CcSEcCtD
Octreotide—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00019	0.000331	CcSEcCtD
Octreotide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.00019	0.00033	CcSEcCtD
Octreotide—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.00019	0.00033	CcSEcCtD
Octreotide—Vertigo—Losartan—type 2 diabetes mellitus	0.00019	0.00033	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00019	0.00033	CcSEcCtD
Octreotide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00019	0.00033	CcSEcCtD
Octreotide—Somnolence—Valsartan—type 2 diabetes mellitus	0.00019	0.000329	CcSEcCtD
Octreotide—Syncope—Losartan—type 2 diabetes mellitus	0.00019	0.000329	CcSEcCtD
Octreotide—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000189	0.000329	CcSEcCtD
Octreotide—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000189	0.000328	CcSEcCtD
Octreotide—Skin disorder—Metformin—type 2 diabetes mellitus	0.000189	0.000328	CcSEcCtD
Octreotide—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000188	0.000327	CcSEcCtD
Octreotide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000188	0.000326	CcSEcCtD
Octreotide—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000188	0.000326	CcSEcCtD
Octreotide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000187	0.000325	CcSEcCtD
Octreotide—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000187	0.000325	CcSEcCtD
Octreotide—Palpitations—Losartan—type 2 diabetes mellitus	0.000187	0.000324	CcSEcCtD
Octreotide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000186	0.000323	CcSEcCtD
Octreotide—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000186	0.000323	CcSEcCtD
Octreotide—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000186	0.000323	CcSEcCtD
Octreotide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000186	0.000322	CcSEcCtD
Octreotide—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000186	0.000322	CcSEcCtD
Octreotide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000186	0.000322	CcSEcCtD
Octreotide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000185	0.000322	CcSEcCtD
Octreotide—Anorexia—Metformin—type 2 diabetes mellitus	0.000185	0.000322	CcSEcCtD
Octreotide—Cough—Losartan—type 2 diabetes mellitus	0.000184	0.00032	CcSEcCtD
Octreotide—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000184	0.00032	CcSEcCtD
Octreotide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000184	0.00032	CcSEcCtD
Octreotide—Alopecia—Ramipril—type 2 diabetes mellitus	0.000184	0.00032	CcSEcCtD
Octreotide—Fatigue—Valsartan—type 2 diabetes mellitus	0.000184	0.000319	CcSEcCtD
Octreotide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000184	0.000319	CcSEcCtD
Octreotide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000184	0.000319	CcSEcCtD
Octreotide—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000183	0.000318	CcSEcCtD
Octreotide—Oedema—Irbesartan—type 2 diabetes mellitus	0.000183	0.000318	CcSEcCtD
Octreotide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000183	0.000318	CcSEcCtD
Octreotide—Pruritus—Glyburide—type 2 diabetes mellitus	0.000183	0.000318	CcSEcCtD
Octreotide—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000182	0.000317	CcSEcCtD
Octreotide—Constipation—Valsartan—type 2 diabetes mellitus	0.000182	0.000317	CcSEcCtD
Octreotide—Infection—Irbesartan—type 2 diabetes mellitus	0.000182	0.000316	CcSEcCtD
Octreotide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000182	0.000316	CcSEcCtD
Octreotide—Fatigue—Orlistat—type 2 diabetes mellitus	0.000182	0.000316	CcSEcCtD
Octreotide—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000181	0.000315	CcSEcCtD
Octreotide—Erythema—Ramipril—type 2 diabetes mellitus	0.000181	0.000315	CcSEcCtD
Octreotide—Shock—Irbesartan—type 2 diabetes mellitus	0.00018	0.000313	CcSEcCtD
Octreotide—Pain—Orlistat—type 2 diabetes mellitus	0.00018	0.000313	CcSEcCtD
Octreotide—Chest pain—Losartan—type 2 diabetes mellitus	0.00018	0.000313	CcSEcCtD
Octreotide—Arthralgia—Losartan—type 2 diabetes mellitus	0.00018	0.000313	CcSEcCtD
Octreotide—Myalgia—Losartan—type 2 diabetes mellitus	0.00018	0.000313	CcSEcCtD
Octreotide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00018	0.000312	CcSEcCtD
Octreotide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00018	0.000312	CcSEcCtD
Octreotide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000179	0.000312	CcSEcCtD
Octreotide—Anxiety—Losartan—type 2 diabetes mellitus	0.000179	0.000311	CcSEcCtD
Octreotide—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000179	0.000311	CcSEcCtD
Octreotide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000178	0.00031	CcSEcCtD
Octreotide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000178	0.000309	CcSEcCtD
Octreotide—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000178	0.000309	CcSEcCtD
Octreotide—Tension—Ramipril—type 2 diabetes mellitus	0.000178	0.000309	CcSEcCtD
Octreotide—Discomfort—Losartan—type 2 diabetes mellitus	0.000178	0.000309	CcSEcCtD
Octreotide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000177	0.000308	CcSEcCtD
Octreotide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000177	0.000308	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000177	0.000307	CcSEcCtD
Octreotide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000177	0.000307	CcSEcCtD
Octreotide—Nervousness—Ramipril—type 2 diabetes mellitus	0.000176	0.000306	CcSEcCtD
Octreotide—Dry mouth—Losartan—type 2 diabetes mellitus	0.000176	0.000306	CcSEcCtD
Octreotide—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000175	0.000303	CcSEcCtD
Octreotide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000174	0.000303	CcSEcCtD
Octreotide—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000174	0.000303	CcSEcCtD
Octreotide—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000174	0.000303	CcSEcCtD
Octreotide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000174	0.000302	CcSEcCtD
Octreotide—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000173	0.000301	CcSEcCtD
Octreotide—Somnolence—Metformin—type 2 diabetes mellitus	0.000173	0.0003	CcSEcCtD
Octreotide—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000173	0.0003	CcSEcCtD
Octreotide—Oedema—Losartan—type 2 diabetes mellitus	0.000173	0.0003	CcSEcCtD
Octreotide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000172	0.000299	CcSEcCtD
Octreotide—Infection—Losartan—type 2 diabetes mellitus	0.000171	0.000298	CcSEcCtD
Octreotide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000171	0.000297	CcSEcCtD
Octreotide—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000171	0.000297	CcSEcCtD
Octreotide—Tremor—Ramipril—type 2 diabetes mellitus	0.00017	0.000295	CcSEcCtD
Octreotide—Shock—Losartan—type 2 diabetes mellitus	0.00017	0.000295	CcSEcCtD
Octreotide—Urticaria—Valsartan—type 2 diabetes mellitus	0.000169	0.000294	CcSEcCtD
Octreotide—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000169	0.000294	CcSEcCtD
Octreotide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000169	0.000293	CcSEcCtD
Octreotide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000169	0.000293	CcSEcCtD
Octreotide—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000169	0.000293	CcSEcCtD
Octreotide—Tachycardia—Losartan—type 2 diabetes mellitus	0.000168	0.000292	CcSEcCtD
Octreotide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000168	0.000292	CcSEcCtD
Octreotide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000168	0.000292	CcSEcCtD
Octreotide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000168	0.000291	CcSEcCtD
Octreotide—Fatigue—Metformin—type 2 diabetes mellitus	0.000167	0.000291	CcSEcCtD
Octreotide—Urticaria—Orlistat—type 2 diabetes mellitus	0.000167	0.000291	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000167	0.00029	CcSEcCtD
Octreotide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000167	0.00029	CcSEcCtD
Octreotide—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000167	0.000289	CcSEcCtD
Octreotide—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000167	0.000289	CcSEcCtD
Octreotide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000167	0.000289	CcSEcCtD
Octreotide—Agitation—Ramipril—type 2 diabetes mellitus	0.000167	0.000289	CcSEcCtD
Octreotide—Constipation—Metformin—type 2 diabetes mellitus	0.000166	0.000288	CcSEcCtD
Octreotide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000165	0.000286	CcSEcCtD
Octreotide—Anorexia—Losartan—type 2 diabetes mellitus	0.000164	0.000286	CcSEcCtD
Octreotide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000164	0.000286	CcSEcCtD
Octreotide—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000164	0.000285	CcSEcCtD
Octreotide—Malaise—Ramipril—type 2 diabetes mellitus	0.000163	0.000284	CcSEcCtD
Octreotide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000163	0.000284	CcSEcCtD
Octreotide—Rash—Glyburide—type 2 diabetes mellitus	0.000163	0.000283	CcSEcCtD
Octreotide—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000163	0.000283	CcSEcCtD
Octreotide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000163	0.000283	CcSEcCtD
Octreotide—Vertigo—Ramipril—type 2 diabetes mellitus	0.000163	0.000283	CcSEcCtD
Octreotide—Syncope—Ramipril—type 2 diabetes mellitus	0.000163	0.000282	CcSEcCtD
Octreotide—Headache—Glyburide—type 2 diabetes mellitus	0.000162	0.000281	CcSEcCtD
Octreotide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000161	0.00028	CcSEcCtD
Octreotide—Palpitations—Ramipril—type 2 diabetes mellitus	0.00016	0.000278	CcSEcCtD
Octreotide—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00016	0.000278	CcSEcCtD
Octreotide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000159	0.000277	CcSEcCtD
Octreotide—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000159	0.000277	CcSEcCtD
Octreotide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000159	0.000276	CcSEcCtD
Octreotide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000159	0.000276	CcSEcCtD
Octreotide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000158	0.000275	CcSEcCtD
Octreotide—Cough—Ramipril—type 2 diabetes mellitus	0.000158	0.000275	CcSEcCtD
Octreotide—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000158	0.000274	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000157	0.000273	CcSEcCtD
Octreotide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000157	0.000273	CcSEcCtD
Octreotide—Convulsion—Ramipril—type 2 diabetes mellitus	0.000157	0.000273	CcSEcCtD
Octreotide—Pain—Irbesartan—type 2 diabetes mellitus	0.000157	0.000272	CcSEcCtD
Octreotide—Constipation—Irbesartan—type 2 diabetes mellitus	0.000157	0.000272	CcSEcCtD
Octreotide—Insomnia—Losartan—type 2 diabetes mellitus	0.000156	0.000271	CcSEcCtD
Octreotide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000155	0.00027	CcSEcCtD
Octreotide—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000155	0.000269	CcSEcCtD
Octreotide—Urticaria—Metformin—type 2 diabetes mellitus	0.000154	0.000268	CcSEcCtD
Octreotide—Chest pain—Ramipril—type 2 diabetes mellitus	0.000154	0.000268	CcSEcCtD
Octreotide—Myalgia—Ramipril—type 2 diabetes mellitus	0.000154	0.000268	CcSEcCtD
Octreotide—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000154	0.000268	CcSEcCtD
Octreotide—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000154	0.000267	CcSEcCtD
Octreotide—Anxiety—Ramipril—type 2 diabetes mellitus	0.000154	0.000267	CcSEcCtD
Octreotide—Nausea—Glyburide—type 2 diabetes mellitus	0.000154	0.000267	CcSEcCtD
Octreotide—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000154	0.000267	CcSEcCtD
Octreotide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000154	0.000267	CcSEcCtD
Octreotide—Somnolence—Losartan—type 2 diabetes mellitus	0.000153	0.000266	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000153	0.000266	CcSEcCtD
Octreotide—Asthenia—Valsartan—type 2 diabetes mellitus	0.000153	0.000266	CcSEcCtD
Octreotide—Discomfort—Ramipril—type 2 diabetes mellitus	0.000152	0.000265	CcSEcCtD
Octreotide—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000152	0.000264	CcSEcCtD
Octreotide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000151	0.000263	CcSEcCtD
Octreotide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000151	0.000262	CcSEcCtD
Octreotide—Pruritus—Valsartan—type 2 diabetes mellitus	0.000151	0.000262	CcSEcCtD
Octreotide—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000151	0.000262	CcSEcCtD
Octreotide—Decreased appetite—Losartan—type 2 diabetes mellitus	0.00015	0.00026	CcSEcCtD
Octreotide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00015	0.00026	CcSEcCtD
Octreotide—Pruritus—Orlistat—type 2 diabetes mellitus	0.000149	0.000259	CcSEcCtD
Octreotide—Fatigue—Losartan—type 2 diabetes mellitus	0.000149	0.000258	CcSEcCtD
Octreotide—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000148	0.000257	CcSEcCtD
Octreotide—Oedema—Ramipril—type 2 diabetes mellitus	0.000148	0.000257	CcSEcCtD
Octreotide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000148	0.000256	CcSEcCtD
Octreotide—Pain—Losartan—type 2 diabetes mellitus	0.000148	0.000256	CcSEcCtD
Octreotide—Constipation—Losartan—type 2 diabetes mellitus	0.000148	0.000256	CcSEcCtD
Octreotide—Rash—Gliclazide—type 2 diabetes mellitus	0.000146	0.000254	CcSEcCtD
Octreotide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000146	0.000254	CcSEcCtD
Octreotide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000146	0.000253	CcSEcCtD
Octreotide—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000146	0.000253	CcSEcCtD
Octreotide—Shock—Ramipril—type 2 diabetes mellitus	0.000146	0.000253	CcSEcCtD
Octreotide—Headache—Gliclazide—type 2 diabetes mellitus	0.000145	0.000253	CcSEcCtD
Octreotide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000145	0.000252	CcSEcCtD
Octreotide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000145	0.000252	CcSEcCtD
Octreotide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000145	0.000252	CcSEcCtD
Octreotide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000145	0.000252	CcSEcCtD
Octreotide—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000144	0.000251	CcSEcCtD
Octreotide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000144	0.00025	CcSEcCtD
Octreotide—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000144	0.00025	CcSEcCtD
Octreotide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000143	0.000248	CcSEcCtD
Octreotide—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000142	0.000247	CcSEcCtD
Octreotide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000141	0.000245	CcSEcCtD
Octreotide—Dizziness—Valsartan—type 2 diabetes mellitus	0.000141	0.000245	CcSEcCtD
Octreotide—Anorexia—Ramipril—type 2 diabetes mellitus	0.000141	0.000245	CcSEcCtD
Octreotide—Dizziness—Orlistat—type 2 diabetes mellitus	0.000139	0.000242	CcSEcCtD
Octreotide—Asthenia—Metformin—type 2 diabetes mellitus	0.000139	0.000242	CcSEcCtD
Octreotide—Nausea—Gliclazide—type 2 diabetes mellitus	0.000138	0.00024	CcSEcCtD
Octreotide—Pruritus—Metformin—type 2 diabetes mellitus	0.000137	0.000239	CcSEcCtD
Octreotide—Urticaria—Losartan—type 2 diabetes mellitus	0.000137	0.000238	CcSEcCtD
Octreotide—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000136	0.000237	CcSEcCtD
Octreotide—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000136	0.000237	CcSEcCtD
Octreotide—Vomiting—Valsartan—type 2 diabetes mellitus	0.000136	0.000236	CcSEcCtD
Octreotide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000135	0.000235	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000135	0.000234	CcSEcCtD
Octreotide—Rash—Valsartan—type 2 diabetes mellitus	0.000134	0.000234	CcSEcCtD
Octreotide—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000134	0.000233	CcSEcCtD
Octreotide—Vomiting—Orlistat—type 2 diabetes mellitus	0.000134	0.000233	CcSEcCtD
Octreotide—Insomnia—Ramipril—type 2 diabetes mellitus	0.000134	0.000232	CcSEcCtD
Octreotide—Headache—Valsartan—type 2 diabetes mellitus	0.000134	0.000232	CcSEcCtD
Octreotide—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000133	0.000231	CcSEcCtD
Octreotide—Rash—Orlistat—type 2 diabetes mellitus	0.000133	0.000231	CcSEcCtD
Octreotide—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000133	0.000231	CcSEcCtD
Octreotide—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000133	0.000231	CcSEcCtD
Octreotide—Headache—Orlistat—type 2 diabetes mellitus	0.000132	0.000229	CcSEcCtD
Octreotide—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000132	0.000229	CcSEcCtD
Octreotide—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000132	0.000228	CcSEcCtD
Octreotide—Somnolence—Ramipril—type 2 diabetes mellitus	0.000132	0.000228	CcSEcCtD
Octreotide—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.00013	0.000226	CcSEcCtD
Octreotide—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00013	0.000225	CcSEcCtD
Octreotide—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000129	0.000223	CcSEcCtD
Octreotide—Dizziness—Metformin—type 2 diabetes mellitus	0.000128	0.000223	CcSEcCtD
Octreotide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000128	0.000222	CcSEcCtD
Octreotide—Fatigue—Ramipril—type 2 diabetes mellitus	0.000128	0.000221	CcSEcCtD
Octreotide—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000127	0.000221	CcSEcCtD
Octreotide—Nausea—Valsartan—type 2 diabetes mellitus	0.000127	0.00022	CcSEcCtD
Octreotide—Constipation—Ramipril—type 2 diabetes mellitus	0.000126	0.00022	CcSEcCtD
Octreotide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000125	0.000218	CcSEcCtD
Octreotide—Nausea—Orlistat—type 2 diabetes mellitus	0.000125	0.000217	CcSEcCtD
Octreotide—Asthenia—Losartan—type 2 diabetes mellitus	0.000124	0.000215	CcSEcCtD
Octreotide—Vomiting—Metformin—type 2 diabetes mellitus	0.000124	0.000214	CcSEcCtD
Octreotide—Rash—Metformin—type 2 diabetes mellitus	0.000122	0.000213	CcSEcCtD
Octreotide—Dermatitis—Metformin—type 2 diabetes mellitus	0.000122	0.000213	CcSEcCtD
Octreotide—Pruritus—Losartan—type 2 diabetes mellitus	0.000122	0.000212	CcSEcCtD
Octreotide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000122	0.000212	CcSEcCtD
Octreotide—Headache—Metformin—type 2 diabetes mellitus	0.000122	0.000211	CcSEcCtD
Octreotide—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000121	0.000211	CcSEcCtD
Octreotide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000121	0.00021	CcSEcCtD
Octreotide—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000118	0.000205	CcSEcCtD
Octreotide—Urticaria—Ramipril—type 2 diabetes mellitus	0.000118	0.000204	CcSEcCtD
Octreotide—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000117	0.000203	CcSEcCtD
Octreotide—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000117	0.000203	CcSEcCtD
Octreotide—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000117	0.000202	CcSEcCtD
Octreotide—Rash—Irbesartan—type 2 diabetes mellitus	0.000116	0.000201	CcSEcCtD
Octreotide—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000115	0.000201	CcSEcCtD
Octreotide—Nausea—Metformin—type 2 diabetes mellitus	0.000115	0.0002	CcSEcCtD
Octreotide—Headache—Irbesartan—type 2 diabetes mellitus	0.000115	0.000199	CcSEcCtD
Octreotide—Dizziness—Losartan—type 2 diabetes mellitus	0.000114	0.000198	CcSEcCtD
Octreotide—Vomiting—Losartan—type 2 diabetes mellitus	0.00011	0.00019	CcSEcCtD
Octreotide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000109	0.000189	CcSEcCtD
Octreotide—Nausea—Irbesartan—type 2 diabetes mellitus	0.000109	0.000189	CcSEcCtD
Octreotide—Rash—Losartan—type 2 diabetes mellitus	0.000109	0.000189	CcSEcCtD
Octreotide—Dermatitis—Losartan—type 2 diabetes mellitus	0.000109	0.000189	CcSEcCtD
Octreotide—Headache—Losartan—type 2 diabetes mellitus	0.000108	0.000188	CcSEcCtD
Octreotide—Asthenia—Ramipril—type 2 diabetes mellitus	0.000106	0.000184	CcSEcCtD
Octreotide—Pruritus—Ramipril—type 2 diabetes mellitus	0.000105	0.000182	CcSEcCtD
Octreotide—Nausea—Losartan—type 2 diabetes mellitus	0.000102	0.000178	CcSEcCtD
Octreotide—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000101	0.000176	CcSEcCtD
Octreotide—Dizziness—Ramipril—type 2 diabetes mellitus	9.78e-05	0.00017	CcSEcCtD
Octreotide—Vomiting—Ramipril—type 2 diabetes mellitus	9.4e-05	0.000163	CcSEcCtD
Octreotide—Rash—Ramipril—type 2 diabetes mellitus	9.33e-05	0.000162	CcSEcCtD
Octreotide—Dermatitis—Ramipril—type 2 diabetes mellitus	9.32e-05	0.000162	CcSEcCtD
Octreotide—Headache—Ramipril—type 2 diabetes mellitus	9.27e-05	0.000161	CcSEcCtD
Octreotide—Nausea—Ramipril—type 2 diabetes mellitus	8.79e-05	0.000153	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—C3—type 2 diabetes mellitus	7.8e-05	0.0002	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PLAT—type 2 diabetes mellitus	7.77e-05	0.000199	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—GHRL—type 2 diabetes mellitus	7.77e-05	0.000199	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.69e-05	0.000197	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.68e-05	0.000197	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CALCA—type 2 diabetes mellitus	7.68e-05	0.000197	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	7.59e-05	0.000194	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	7.57e-05	0.000194	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	7.57e-05	0.000194	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7.5e-05	0.000192	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	7.47e-05	0.000191	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AGT—type 2 diabetes mellitus	7.46e-05	0.000191	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.44e-05	0.000191	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.42e-05	0.00019	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AGT—type 2 diabetes mellitus	7.41e-05	0.00019	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.37e-05	0.000189	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.36e-05	0.000189	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	7.36e-05	0.000189	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	7.33e-05	0.000188	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CYBA—type 2 diabetes mellitus	7.33e-05	0.000188	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.28e-05	0.000187	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.28e-05	0.000186	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—LEP—type 2 diabetes mellitus	7.26e-05	0.000186	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—APOE—type 2 diabetes mellitus	7.26e-05	0.000186	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	7.23e-05	0.000185	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.21e-05	0.000185	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	7.21e-05	0.000185	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	7.2e-05	0.000184	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PLAT—type 2 diabetes mellitus	7.17e-05	0.000184	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—GHRL—type 2 diabetes mellitus	7.17e-05	0.000184	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.17e-05	0.000184	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AVP—type 2 diabetes mellitus	7.11e-05	0.000182	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTPN1—type 2 diabetes mellitus	7.11e-05	0.000182	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—GCG—type 2 diabetes mellitus	7.11e-05	0.000182	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.11e-05	0.000182	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CALCA—type 2 diabetes mellitus	7.09e-05	0.000182	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.08e-05	0.000181	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.05e-05	0.000181	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	7e-05	0.000179	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.98e-05	0.000179	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.97e-05	0.000179	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	6.97e-05	0.000179	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.91e-05	0.000177	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	6.89e-05	0.000177	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APOB—type 2 diabetes mellitus	6.87e-05	0.000176	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.84e-05	0.000175	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.84e-05	0.000175	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AVP—type 2 diabetes mellitus	6.82e-05	0.000175	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.82e-05	0.000175	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.79e-05	0.000174	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.76e-05	0.000173	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.76e-05	0.000173	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.69e-05	0.000171	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	6.67e-05	0.000171	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CCL2—type 2 diabetes mellitus	6.65e-05	0.000171	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	6.64e-05	0.00017	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APOB—type 2 diabetes mellitus	6.59e-05	0.000169	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	6.56e-05	0.000168	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—GCG—type 2 diabetes mellitus	6.56e-05	0.000168	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—LPL—type 2 diabetes mellitus	6.56e-05	0.000168	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.56e-05	0.000168	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AKT2—type 2 diabetes mellitus	6.54e-05	0.000168	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	6.53e-05	0.000167	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.48e-05	0.000166	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.47e-05	0.000166	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	6.46e-05	0.000165	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	6.44e-05	0.000165	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.42e-05	0.000165	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—LPL—type 2 diabetes mellitus	6.29e-05	0.000161	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—INS—type 2 diabetes mellitus	6.2e-05	0.000159	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.19e-05	0.000159	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.16e-05	0.000158	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.16e-05	0.000158	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	6.14e-05	0.000157	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.13e-05	0.000157	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.1e-05	0.000156	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.05e-05	0.000155	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AVP—type 2 diabetes mellitus	6.05e-05	0.000155	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.05e-05	0.000155	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	6.03e-05	0.000155	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	6.03e-05	0.000154	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.02e-05	0.000154	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IGF1—type 2 diabetes mellitus	6e-05	0.000154	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.99e-05	0.000154	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.99e-05	0.000154	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.97e-05	0.000153	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.93e-05	0.000152	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—C3—type 2 diabetes mellitus	5.91e-05	0.000151	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.9e-05	0.000151	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APOB—type 2 diabetes mellitus	5.84e-05	0.00015	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.82e-05	0.000149	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.8e-05	0.000149	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.75e-05	0.000147	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	5.71e-05	0.000146	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.7e-05	0.000146	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—C3—type 2 diabetes mellitus	5.66e-05	0.000145	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—GNB3—type 2 diabetes mellitus	5.66e-05	0.000145	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.63e-05	0.000144	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.62e-05	0.000144	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AGT—type 2 diabetes mellitus	5.61e-05	0.000144	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—LPL—type 2 diabetes mellitus	5.58e-05	0.000143	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AVP—type 2 diabetes mellitus	5.58e-05	0.000143	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP3—type 2 diabetes mellitus	5.58e-05	0.000143	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IGF2—type 2 diabetes mellitus	5.56e-05	0.000142	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.53e-05	0.000142	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.52e-05	0.000141	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APOE—type 2 diabetes mellitus	5.5e-05	0.000141	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—LEP—type 2 diabetes mellitus	5.5e-05	0.000141	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.47e-05	0.00014	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.46e-05	0.00014	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.44e-05	0.000139	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.44e-05	0.000139	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.44e-05	0.000139	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.4e-05	0.000138	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOB—type 2 diabetes mellitus	5.39e-05	0.000138	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.39e-05	0.000138	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AGT—type 2 diabetes mellitus	5.38e-05	0.000138	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.37e-05	0.000138	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.31e-05	0.000136	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.29e-05	0.000136	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APOE—type 2 diabetes mellitus	5.27e-05	0.000135	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—LEP—type 2 diabetes mellitus	5.27e-05	0.000135	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.24e-05	0.000134	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.21e-05	0.000134	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.19e-05	0.000133	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LPL—type 2 diabetes mellitus	5.15e-05	0.000132	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.14e-05	0.000132	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RELA—type 2 diabetes mellitus	5.12e-05	0.000131	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.04e-05	0.000129	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—C3—type 2 diabetes mellitus	5.02e-05	0.000129	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.97e-05	0.000127	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.91e-05	0.000126	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.83e-05	0.000124	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.79e-05	0.000123	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.78e-05	0.000122	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AGT—type 2 diabetes mellitus	4.77e-05	0.000122	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.74e-05	0.000122	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.7e-05	0.000121	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—INS—type 2 diabetes mellitus	4.7e-05	0.00012	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.69e-05	0.00012	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—LEP—type 2 diabetes mellitus	4.68e-05	0.00012	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APOE—type 2 diabetes mellitus	4.68e-05	0.00012	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.66e-05	0.000119	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—C3—type 2 diabetes mellitus	4.64e-05	0.000119	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.62e-05	0.000118	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.62e-05	0.000118	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.62e-05	0.000118	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.59e-05	0.000118	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.55e-05	0.000116	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.54e-05	0.000116	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.52e-05	0.000116	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—INS—type 2 diabetes mellitus	4.51e-05	0.000115	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.43e-05	0.000114	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.42e-05	0.000113	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.41e-05	0.000113	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.41e-05	0.000113	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AGT—type 2 diabetes mellitus	4.41e-05	0.000113	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.36e-05	0.000112	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.36e-05	0.000112	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.35e-05	0.000112	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.34e-05	0.000111	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.33e-05	0.000111	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOE—type 2 diabetes mellitus	4.32e-05	0.000111	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.32e-05	0.000111	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LEP—type 2 diabetes mellitus	4.32e-05	0.000111	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.32e-05	0.000111	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.27e-05	0.000109	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.23e-05	0.000108	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.17e-05	0.000107	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.14e-05	0.000106	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.12e-05	0.000106	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.12e-05	0.000106	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.07e-05	0.000104	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SRC—type 2 diabetes mellitus	4.02e-05	0.000103	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—INS—type 2 diabetes mellitus	4e-05	0.000102	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.95e-05	0.000101	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.95e-05	0.000101	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.93e-05	0.000101	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.92e-05	0.0001	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RELA—type 2 diabetes mellitus	3.88e-05	9.94e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.86e-05	9.9e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.86e-05	9.9e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.85e-05	9.87e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.85e-05	9.85e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.72e-05	9.53e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—INS—type 2 diabetes mellitus	3.69e-05	9.45e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.67e-05	9.4e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.63e-05	9.3e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.6e-05	9.21e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.57e-05	9.14e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.56e-05	9.13e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.55e-05	9.09e-05	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.53e-05	9.05e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.53e-05	9.03e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.5e-05	8.98e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.5e-05	8.98e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.5e-05	8.96e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.48e-05	8.91e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.39e-05	8.68e-05	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.39e-05	8.67e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.35e-05	8.59e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.33e-05	8.54e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.31e-05	8.47e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RELA—type 2 diabetes mellitus	3.3e-05	8.45e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.27e-05	8.38e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.23e-05	8.29e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.23e-05	8.29e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.21e-05	8.22e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.17e-05	8.12e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.14e-05	8.04e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.07e-05	7.88e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SRC—type 2 diabetes mellitus	3.05e-05	7.81e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RELA—type 2 diabetes mellitus	3.04e-05	7.8e-05	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3e-05	7.69e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.97e-05	7.62e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.97e-05	7.61e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.96e-05	7.57e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.92e-05	7.49e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.85e-05	7.29e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.81e-05	7.2e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.78e-05	7.13e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.77e-05	7.1e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.75e-05	7.03e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.73e-05	6.99e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.73e-05	6.99e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.72e-05	6.98e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6—type 2 diabetes mellitus	2.71e-05	6.94e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.67e-05	6.85e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.61e-05	6.69e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.59e-05	6.65e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SRC—type 2 diabetes mellitus	2.59e-05	6.64e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.57e-05	6.58e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.56e-05	6.56e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.52e-05	6.47e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.52e-05	6.45e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.5e-05	6.4e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.39e-05	6.13e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.33e-05	5.97e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.32e-05	5.94e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.27e-05	5.82e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.14e-05	5.48e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.1e-05	5.37e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.05e-05	5.26e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.97e-05	5.04e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.89e-05	4.85e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.82e-05	4.65e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6—type 2 diabetes mellitus	1.75e-05	4.47e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.61e-05	4.13e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.61e-05	4.13e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.49e-05	3.81e-05	CbGpPWpGaD
